Stay updated on Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial
Sign up to get notified when there's something new on the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page.

Latest updates to the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%
- Check15 days agoChange DetectedAdds updated contact details and a new revision tag (v3.1.0); removes an older revision tag (v3.0.2) and the Biopsy, Large-Core Needle term. Overall, the page now reflects updated contact info and versioning with a slight update to the stated procedure nomenclature.SummaryDifference0.4%
- Check22 days agoChange DetectedUpdated trial page with new dates, added meta labels (Principal Investigator, Last Update Posted (Estimated)), and slightly reformatted title; older dates and Contact label removed. Overall meaning remains the same but with refreshed metadata and timing.SummaryDifference0.9%
- Check29 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; no substantive content changes. The 'Back to Top' link was removed as a minor UI cleanup.SummaryDifference0.2%
- Check36 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated to include new drug information and specific medical procedures, while removing previous references to locations and certain cancer-related topics.SummaryDifference5%
Stay in the know with updates to Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Peri-Op Checkpoint Inhibition+Cryoablation in TNBC Clinical Trial page.